425: Strive CIO Posts Merger Cautionary Statement

Strive's Chief Investment Officer posted a communication on X.com regarding the proposed business combination with Semler Scientific, emphasizing cautionary statements about forward-looking information and associated risks.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc.
• The communication, posted by Strive's CIO Ben Werkman on X.com on November 18, 2025, primarily serves as a cautionary statement regarding forward-looking statements.
• It highlights inherent risks and uncertainties associated with the merger, including the realization of strategic and financial benefits, timing of closing, and integration challenges.
• Investors are urged to read the Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus for important information.

Sentiment

Score: 4

Explanation: The filing is a formal cautionary statement primarily focused on outlining numerous risks and uncertainties associated with a proposed merger. While it mentions expected benefits, the overwhelming emphasis is on potential negative outcomes and the need for investors to exercise caution, leading to a slightly negative sentiment.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated.
• The proposed transaction may not close when expected or at all if closing conditions are not met.
• Legal proceedings could be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and regulatory enforcement could impact anticipated benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution may occur due to Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from customers or changes to business or employee relationships may arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The filing reiterates forward-looking statements concerning the proposed transaction's outlook, expected strategic and financial benefits, impact on future financial performance, timing of closing, and ability to successfully integrate the combined businesses. However, it strongly cautions against relying too heavily on these statements due to inherent risks and uncertainties.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., posted the communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with Bitcoin treasury strategies and other digital assets, indicating that the combined entity may be exposed to or pursuing strategies involving cryptocurrencies, which is a notable trend in certain sectors but also introduces specific market and regulatory risks.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Shareholders: Semler Scientific stockholders will need to vote on the proposed transaction and face potential dilution from Strive's stock issuance. All shareholders face risks related to the transaction's success and integration.
• Customers: Potential for adverse reactions to the merger.
• Employees: Potential for changes to business or employee relationships.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific will continue to file relevant documents with the SEC.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin, digital assets, corporate governance, investment risk